Research integrity


Fraud or sloppiness in a submitted manuscript


In June 2014 we received a manuscript by four authors from a well known research institution. They described a randomized trial comparing a variation in a procedure with standard care. In total, 200 patients were randomized, 100 to each arm. As measured by an interview, patients undergoing the new procedure were statistically significantly more content than those in the control arm.


Programme for COPE European Seminar 2014, Brussels, Belgium, 14 March 2014

in cooperation with the Representation of the State of Hessen to the European Union

Venue: Representation of the State of Hessen to the European Union, Rue Montoyer 21, 1000 Brussels, Belgium


Ethical concerns about a study involving human subjects


A manuscript was submitted to our journal describing a study of a new drug. The manuscript had only one author who gave their affiliation as a company that we can find no record of online. It describes a study in which they appear to have developed a new drug, carried out a toxicology study in mice and then, because no adverse effects were seen, tested it on one patient and five healthy volunteers. There appear to have be no stages in between.

About this resource

Full page history

  • 18 February 2019

    Transferred to 'resources* from on 14th Feb 2019


Suspect author


Author A has published approximately 150 original articles since ~1994, with ~100 on one particular topic. Since some of these events were up to 16 years ago, and there are no formal records from then relating to these studies, the only information we have is the memory of the editors of the affected journals in post at the time.


Falsification of certificates of deposit of new bacterial species in culture collections


The process of naming and describing novel species of bacteria is governed by the Bacteriological Code.